BLUE BIRD CORP (BLBD)

US0953061068 - Common Stock

39.37  -1.36 (-3.34%)

After market: 39.37 0 (0%)

Fundamental Rating

6

Overall BLBD gets a fundamental rating of 6 out of 10. We evaluated BLBD against 132 industry peers in the Machinery industry. Both the profitability and the financial health of BLBD get a neutral evaluation. Nothing too spectacular is happening here. BLBD scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make BLBD a good candidate for value investing.



6

1. Profitability

1.1 Basic Checks

In the past year BLBD was profitable.
BLBD had a positive operating cash flow in the past year.
In multiple years BLBD reported negative net income over the last 5 years.
In multiple years BLBD reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 20.11%, BLBD belongs to the top of the industry, outperforming 98.46% of the companies in the same industry.
With an excellent Return On Equity value of 66.15%, BLBD belongs to the best of the industry, outperforming 98.46% of the companies in the same industry.
BLBD has a better Return On Invested Capital (33.55%) than 99.23% of its industry peers.
Industry RankSector Rank
ROA 20.11%
ROE 66.15%
ROIC 33.55%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a decent Profit Margin value of 7.83%, BLBD is doing good in the industry, outperforming 62.31% of the companies in the same industry.
In the last couple of years the Profit Margin of BLBD has grown nicely.
BLBD has a Operating Margin of 10.34%. This is comparable to the rest of the industry: BLBD outperforms 55.38% of its industry peers.
BLBD's Operating Margin has improved in the last couple of years.
BLBD has a Gross Margin of 19.01%. This is in the lower half of the industry: BLBD underperforms 74.62% of its industry peers.
BLBD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.34%
PM (TTM) 7.83%
GM 19.01%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%

6

2. Health

2.1 Basic Checks

BLBD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, BLBD has more shares outstanding
Compared to 5 years ago, BLBD has more shares outstanding
Compared to 1 year ago, BLBD has an improved debt to assets ratio.

2.2 Solvency

BLBD has an Altman-Z score of 5.73. This indicates that BLBD is financially healthy and has little risk of bankruptcy at the moment.
BLBD's Altman-Z score of 5.73 is fine compared to the rest of the industry. BLBD outperforms 78.46% of its industry peers.
BLBD has a debt to FCF ratio of 1.00. This is a very positive value and a sign of high solvency as it would only need 1.00 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.00, BLBD belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
BLBD has a Debt/Equity ratio of 0.56. This is a neutral value indicating BLBD is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.56, BLBD is doing worse than 60.77% of the companies in the same industry.
Although BLBD does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 1
Altman-Z 5.73
ROIC/WACC3.72
WACC9.02%

2.3 Liquidity

A Current Ratio of 1.37 indicates that BLBD should not have too much problems paying its short term obligations.
BLBD has a Current ratio of 1.37. This is amonst the worse of the industry: BLBD underperforms 80.77% of its industry peers.
A Quick Ratio of 0.83 indicates that BLBD may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.83, BLBD is doing worse than 78.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.83

6

3. Growth

3.1 Past

BLBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 225.23%, which is quite impressive.
Measured over the past years, BLBD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.38% on average per year.
Looking at the last year, BLBD shows a quite strong growth in Revenue. The Revenue has grown by 18.93% in the last year.
BLBD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.74% yearly.
EPS 1Y (TTM)225.23%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%16.67%
Revenue 1Y (TTM)18.93%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%15.6%

3.2 Future

Based on estimates for the next years, BLBD will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.01% on average per year.
Based on estimates for the next years, BLBD will show a quite strong growth in Revenue. The Revenue will grow by 8.93% on average per year.
EPS Next Y14.54%
EPS Next 2Y14.05%
EPS Next 3Y9.01%
EPS Next 5YN/A
Revenue Next Year10.2%
Revenue Next 2Y9.39%
Revenue Next 3Y8.93%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

8

4. Valuation

4.1 Price/Earnings Ratio

BLBD is valuated reasonably with a Price/Earnings ratio of 11.31.
BLBD's Price/Earnings ratio is rather cheap when compared to the industry. BLBD is cheaper than 87.69% of the companies in the same industry.
When comparing the Price/Earnings ratio of BLBD to the average of the S&P500 Index (27.20), we can say BLBD is valued rather cheaply.
BLBD is valuated reasonably with a Price/Forward Earnings ratio of 9.88.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BLBD indicates a rather cheap valuation: BLBD is cheaper than 93.08% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of BLBD to the average of the S&P500 Index (23.73), we can say BLBD is valued rather cheaply.
Industry RankSector Rank
PE 11.31
Fwd PE 9.88

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BLBD is valued cheaply inside the industry as 83.85% of the companies are valued more expensively.
BLBD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BLBD is cheaper than 91.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.25
EV/EBITDA 8.04

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of BLBD may justify a higher PE ratio.
PEG (NY)0.78
PEG (5Y)0.69
EPS Next 2Y14.05%
EPS Next 3Y9.01%

0

5. Dividend

5.1 Amount

BLBD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUE BIRD CORP

NASDAQ:BLBD (12/20/2024, 8:00:01 PM)

After market: 39.37 0 (0%)

39.37

-1.36 (-3.34%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-25 2024-11-25/amc
Earnings (Next)02-05 2025-02-05/amc
Inst Owners89.58%
Inst Owner Change6.34%
Ins Owners0.05%
Ins Owner Change1.74%
Market Cap1.27B
Analysts82.86
Price Target57.57 (46.23%)
Short Float %17.22%
Short Ratio6.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)44.68%
Min EPS beat(2)15.25%
Max EPS beat(2)74.11%
EPS beat(4)4
Avg EPS beat(4)76.87%
Min EPS beat(4)15.25%
Max EPS beat(4)138.23%
EPS beat(8)8
Avg EPS beat(8)80.41%
EPS beat(12)9
Avg EPS beat(12)-106.57%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.67%
Min Revenue beat(2)-0.54%
Max Revenue beat(2)3.87%
Revenue beat(4)3
Avg Revenue beat(4)7.54%
Min Revenue beat(4)-0.54%
Max Revenue beat(4)13.65%
Revenue beat(8)7
Avg Revenue beat(8)7.62%
Revenue beat(12)10
Avg Revenue beat(12)10.01%
Revenue beat(16)10
Avg Revenue beat(16)4.14%
PT rev (1m)-2.69%
PT rev (3m)-3.41%
EPS NQ rev (1m)61.01%
EPS NQ rev (3m)61.01%
EPS NY rev (1m)5.95%
EPS NY rev (3m)7.12%
Revenue NQ rev (1m)-1.98%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)0.54%
Revenue NY rev (3m)0.54%
Valuation
Industry RankSector Rank
PE 11.31
Fwd PE 9.88
P/S 0.94
P/FCF 13.25
P/OCF 11.43
P/B 7.96
P/tB 13.07
EV/EBITDA 8.04
EPS(TTM)3.48
EY8.84%
EPS(NY)3.99
Fwd EY10.12%
FCF(TTM)2.97
FCFY7.54%
OCF(TTM)3.44
OCFY8.75%
SpS41.75
BVpS4.94
TBVpS3.01
PEG (NY)0.78
PEG (5Y)0.69
Profitability
Industry RankSector Rank
ROA 20.11%
ROE 66.15%
ROCE 48.22%
ROIC 33.55%
ROICexc 60.11%
ROICexgc 98.05%
OM 10.34%
PM (TTM) 7.83%
GM 19.01%
FCFM 7.11%
ROA(3y)4.43%
ROA(5y)3.41%
ROE(3y)-1048.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y220.13%
ROICexcg growth 5Y10.5%
ROICexc growth 3Y207.87%
ROICexc growth 5Y19.73%
OM growth 3Y121.61%
OM growth 5Y19.19%
PM growth 3YN/A
PM growth 5Y26.86%
GM growth 3Y21.73%
GM growth 5Y7.73%
F-Score8
Asset Turnover2.57
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 1
Debt/EBITDA 0.58
Cap/Depr 102.99%
Cap/Sales 1.13%
Interest Coverage 14.03
Cash Conversion 72.08%
Profit Quality 90.81%
Current Ratio 1.37
Quick Ratio 0.83
Altman-Z 5.73
F-Score8
WACC9.02%
ROIC/WACC3.72
Cap/Depr(3y)67.41%
Cap/Depr(5y)84.95%
Cap/Sales(3y)0.9%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)225.23%
EPS 3Y123.91%
EPS 5Y16.38%
EPS Q2Q%16.67%
EPS Next Y14.54%
EPS Next 2Y14.05%
EPS Next 3Y9.01%
EPS Next 5YN/A
Revenue 1Y (TTM)18.93%
Revenue growth 3Y25.35%
Revenue growth 5Y5.74%
Sales Q2Q%15.6%
Revenue Next Year10.2%
Revenue Next 2Y9.39%
Revenue Next 3Y8.93%
Revenue Next 5YN/A
EBIT growth 1Y166.58%
EBIT growth 3Y177.79%
EBIT growth 5Y26.04%
EBIT Next Year34.69%
EBIT Next 3Y21.57%
EBIT Next 5YN/A
FCF growth 1Y-13.97%
FCF growth 3YN/A
FCF growth 5Y36.54%
OCF growth 1Y-7.35%
OCF growth 3YN/A
OCF growth 5Y14.81%